H
HIMS
Hims & Hers Health, Inc.
$27.72
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Hims & Hers Health, Inc. in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.63
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $0.06
Nov 2
Posts
No posts about HIMS yet.
About Hims & Hers Health, Inc.
Hims & Hers Health runs an online platform that connects customers with licensed doctors and ships prescription and non-prescription treatments straight to their door. Its subscription business covers hair loss, erectile dysfunction, skin care, mental health, and weight-loss drugs including GLP-1 medications. The company makes money from recurring subscription fees and product sales, skipping the traditional pharmacy visit.